Human rights guidelines for pharmaceutical companies in relation to access to medicines

HUNT, Paul

Publication Date 

September 2007
12 p

These draft guidelines consider human rights and the right to the highest attainable standard of health; how to manage their implementation; public policy influence; advocacy and lobbying; research and development for neglected diseases; patents and licensing; quality and technology transfer; pricing, discounting and donations; ethical promotion and marketing; clinical trials; public private partnership; corruption; associations of pharmaceutical companies; and monitoring and accountability

View webpage for full text 

Language 

Type of material